PharmaBoardroom

Interview with John Montgomery , CEO, Alphapharm

Alphapharm recently celebrated its 25th anniversary. In light of this significant milestone, would you give us a brief introduction to the company?…

Interview with Jez Moulding, General Manager, Sanofi Australia

What impact have the PBS reforms had on sanofi-aventis in Australia? Sanofi-aventis has one of the largest portfolios of medicines in Australia,…

Interview with Joyce Lloyd and Munro Neville, Managing Director,…

Would you please introduce Pretium’s specific service offerings, and the focus within these? Pretium offers a comprehensive range of integrated…

Interview with Andrew Carter, Managing Director, Commercial Eyes

What are some of the challenges facing pharmaceutical companies in Australia today? There are four major challenges within the Australian…

Interview with Ralf Dahmen, Managing Director, Galderma

As ASMI President and Managing Director of Galderma, would you please give us a brief overview of the Australian OTC market and Galderma’s role…

Interview with Richard Davies, Managing Director, Amgen Australia

What impact have the PBS reforms had on Amgen in Australia? From a company perspective, biotechnology companies exist in a competitive space. They…

Interview with Will Delaat, Chairman, Pharmaceutical Industry…

2006 marked a major milestone, with the Pharmaceutical Industry Action Agenda transformed from a Government-industry initiative into an…

Interview with Alek Safarian , Managing Director, Novotech…

One of the hot topics in the industry is the impact of PBS reforms. Can you speak to recent influence of PBS reforms affecting Novotech’s…

Interview with Rob Botha, Vice President UTI Pharma Africa, UTI…

We interviewed Graham Somerville in 2004, the year when IHD, formerly jointly owned by 11 major pharmaceutical companies, was acquired by UTi. We are…

Interview with Jean-Pierre Salama, CEO, Pharmacor

Pharmacor is one of the newest entities on the Australian pharmaceutical market. Would you please introduce the company to let Pharmaceutical…

Interview with Willem Dekker , Regional Director, Nycomed…

What impact have the PBS reforms had on Nycomed? As most mid size Pharma companies that operate in a setting of mass market prescription medicines,…

Interview with Lloyd Sansom, Emeritus Professor, Australia

Would you please introduce the PBAC and the role it plays in Australia’s pharmaceutical sector? The Pharmaceutical Benefits Advisory Committee…

Tagged with